ORAXION

At Oraxion, we are developing a class of polymer drugs that target diseases where aberrant cholesterol and lipid accumulation is implicated as one of the key causes. We are advancing a diverse pipeline covering a broad range of rare diseases with our partners who have extensive expertise in disease biology... Oraxion aims to develop therapeutics for these rare diseases with a high unmet medical need. We are leveraging our technology platform to develop novel therapeutic modalities for debilitating rare diseases with the goal of creating a novel therapeutic intervention that can improve the quality of life for patients significantly... We design platform technologies based on "first principles thinking" to address unmet medical needs. Novel therapeutic solutions are developed by combining materials chemistry and discovery biology. Our agnostic approach to drug discovery allows us to employ diverse technologies for the development and delivery of novel drugs for specific disease..

Also known as: Oraxion Therapeutics